Free Trial

Nanovibronix (NAOV) Competitors

Nanovibronix logo
$6.46 +0.03 (+0.39%)
As of 10:59 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NAOV vs. NVNO, ICU, COCH, HSDT, CTCX, NXL, ALUR, IINN, CODX, and SINT

Should you be buying Nanovibronix stock or one of its competitors? The main competitors of Nanovibronix include enVVeno Medical (NVNO), SeaStar Medical (ICU), Envoy Medical (COCH), Helius Medical Technologies (HSDT), Carmell (CTCX), Nexalin Technology (NXL), Allurion Technologies (ALUR), Inspira Technologies OXY B.H.N. (IINN), Co-Diagnostics (CODX), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry.

Nanovibronix vs. Its Competitors

enVVeno Medical (NASDAQ:NVNO) and Nanovibronix (NASDAQ:NAOV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

Nanovibronix has higher revenue and earnings than enVVeno Medical. enVVeno Medical is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
enVVeno MedicalN/AN/A-$21.82M-$1.20-0.67
Nanovibronix$2.34M2.79-$3.70M-$13.53-0.48

In the previous week, enVVeno Medical had 1 more articles in the media than Nanovibronix. MarketBeat recorded 2 mentions for enVVeno Medical and 1 mentions for Nanovibronix. Nanovibronix's average media sentiment score of 0.95 beat enVVeno Medical's score of 0.53 indicating that Nanovibronix is being referred to more favorably in the news media.

Company Overall Sentiment
enVVeno Medical Positive
Nanovibronix Positive

enVVeno Medical has a net margin of 0.00% compared to Nanovibronix's net margin of -380.29%. Nanovibronix's return on equity of -45.24% beat enVVeno Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
enVVeno MedicalN/A -57.35% -53.49%
Nanovibronix -380.29%-45.24%-34.24%

34.7% of enVVeno Medical shares are owned by institutional investors. Comparatively, 16.4% of Nanovibronix shares are owned by institutional investors. 16.0% of enVVeno Medical shares are owned by insiders. Comparatively, 6.3% of Nanovibronix shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

enVVeno Medical has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 2.17, meaning that its share price is 117% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
enVVeno Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nanovibronix
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Nanovibronix beats enVVeno Medical on 7 of the 13 factors compared between the two stocks.

Get Nanovibronix News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAOV vs. The Competition

MetricNanovibronixMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$6.54M$7.07B$6.16B$10.59B
Dividend YieldN/A1.18%5.73%4.78%
P/E Ratio-0.4826.9085.6727.43
Price / Sales2.7928.63584.77183.24
Price / CashN/A21.7037.3961.86
Price / Book0.355.2312.516.79
Net Income-$3.70M$178.09M$3.32B$276.90M
7 Day Performance-7.51%-1.46%707.60%0.29%
1 Month Performance-15.49%6.62%935.16%7.59%
1 Year Performance-89.17%4.92%2,403.40%39.41%

Nanovibronix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAOV
Nanovibronix
0.415 of 5 stars
$6.47
+0.4%
N/A-88.5%$6.54M$2.34M-0.4820
NVNO
enVVeno Medical
1.0349 of 5 stars
$0.95
-2.3%
N/A-75.3%$18.63MN/A-0.7930
ICU
SeaStar Medical
0.374 of 5 stars
$0.66
+1.6%
N/A-84.5%$18.10M$140K-0.252
COCH
Envoy Medical
2.6495 of 5 stars
$0.81
-0.9%
$9.25
+1,046.5%
-63.9%$17.52M$222K-0.5634Analyst Revision
Gap Up
HSDT
Helius Medical Technologies
1.0292 of 5 stars
$18.19
+12.0%
N/A-94.4%$17.50M$520K-0.0130
CTCX
Carmell
N/A$0.83
+10.7%
N/A+52.1%$17.35M$32.84K0.0014
NXL
Nexalin Technology
2.6441 of 5 stars
$0.93
+1.9%
$5.00
+439.1%
+83.1%$16.06M$170K-1.223Gap Down
ALUR
Allurion Technologies
1.8657 of 5 stars
$2.05
+1.0%
$9.25
+351.2%
-87.9%$15.91M$19.92M-0.16501
IINN
Inspira Technologies OXY B.H.N.
2.4282 of 5 stars
$1.19
-0.8%
$2.00
+68.1%
-15.9%$15.15MN/A0.0020Gap Down
CODX
Co-Diagnostics
4.4085 of 5 stars
$0.38
-1.0%
$5.50
+1,347.4%
-69.6%$14.79M$1.00M-0.33100
SINT
Sintx Technologies
2.0365 of 5 stars
$4.11
+4.3%
$25.00
+508.3%
+48.8%$14.74M$950K-0.0840Gap Up

Related Companies and Tools


This page (NASDAQ:NAOV) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners